Try our Advanced Search for more refined results
Health
-
January 22, 2026
3rd Circ. Says Medical Pot Contract May Violate Federal Law
The Third Circuit on Thursday vacated a medical cannabis company's win in a lawsuit filed by a consultant claiming that it had stolen his trade secrets for growing marijuana samples, finding it couldn't decide the appeal because the parties' contract might have violated federal drug law.
-
January 22, 2026
10th Amtrak Worker Cops To Role In $11M Fraud Scheme
A former Amtrak employee has admitted to participating in a scheme that prosecutors claim defrauded the rail carrier out of $11 million in health benefits, making him the 10th defendant in a year to plead guilty in the case, the U.S. attorney's office in New Jersey said on Thursday.
-
January 22, 2026
Medical Cannabis Co. Says Data Breach Didn't Lead To Injury
An Ohio medical cannabis company has said a consolidated class action in federal court should be dismissed as it doesn't allege any of the plaintiffs' data was accessed in a data breach or that the breach could be linked to any real damage.
-
January 22, 2026
Ex-Surgeon Prevails Over Insurers In Lifetime Disability Fight
A Michigan federal judge handed a disabled surgeon a win against two insurance companies Thursday in his suit seeking total disability benefits for life, siding with the ex-worker's argument that the insurers erred in determining that his condition was caused by sickness instead of injury and cutting off benefits.
-
January 22, 2026
ECJ Backs VAT Exemption For Spanish Cleaning Co-Ops
Spain can't automatically bar cleaning cooperatives from receiving a value-added tax exemption for services provided to educational and healthcare institutions, the European Union's top court ruled Thursday.
-
January 21, 2026
Holmes Seeks Trump Clemency For Theranos Fraud Sentence
Former Theranos CEO Elizabeth Holmes has asked President Donald Trump to commute an 11-year prison sentence she's been serving for defrauding investors with bogus blood-testing technology, according to the U.S. Department of Justice's Office of the Pardon Attorney.
-
January 21, 2026
CVS, UnitedHealth, Express Scripts Duck PBM Antitrust Suit
A Missouri federal judge has thrown out a proposed class action accusing the country's three largest pharmacy benefit managers — owned by CVS, UnitedHealth Group and Cigna Group — of inflating prescription costs through their rebating practices.
-
January 21, 2026
Medtronic 'Blocked' Surgical Device Competition, Jury Told
An executive at Applied Medical Resources Corp. on Tuesday told a California federal jury considering antitrust claims against Medtronic Inc. that a surgical device his company introduced a decade ago had great success in Europe but was "blocked" in the U.S. by Medtronic's practice of "bundling" products.
-
January 21, 2026
Texas AG Launches Investigation Into Vaccine Incentives
The Texas attorney general launched what it characterized as a sweeping, multi-industry investigation into financial incentives for medical providers to recommend childhood vaccines, saying providers regularly dish out vaccines that "are not proven to be safe or necessary."
-
January 21, 2026
Midwives Challenge Miss. Practice Limits In Antitrust Suit
The American College of Nurse-Midwives launched a suit seeking to permanently block Mississippi rules requiring certified nurse-midwives to obtain collaboration agreements with physicians, arguing the rules unlawfully restrict competition and exacerbate public health challenges in the state.
-
January 21, 2026
BCBS Says Bankrupt Hospital Can't Leave $3B Antitrust Deal
Blue Cross Blue Shield is opposing a bankrupt Alabama hospital's bid to opt out of a $2.8 billion antitrust class action settlement to pursue its own claims in bankruptcy court, arguing the hospital has no excuse for missing the deadline.
-
January 21, 2026
Feds Say Medicare Steering Case Meets FCA Legal Bar
The government said Wednesday that its False Claims Act complaint accusing insurers and brokers of participating in a kickback scheme to steer customers to Medicare Advantage plans doesn't conflict with a First Circuit decision last year setting out the standard for such cases.
-
January 21, 2026
Willkie Hires Chicago Restructuring Partner From Kirkland
Willkie Farr & Gallagher LLP has announced it has engaged an attorney from Kirkland & Ellis LLP to join the firm as a partner based in its Chicago office, where it anticipates he will make a successful contribution to a growing corporate restructuring platform.
-
January 21, 2026
Experts Can Testify On Cancer Link In J&J Talc Suits
A special master has said experts for the tens of thousands of women whose suits in New Jersey federal court allege that Johnson & Johnson talc products caused their ovarian cancer can testify at trial about the causal connection between their disease and use of the products.
-
January 21, 2026
Del. Justices Urged To Revive Telemedicine Co. SPAC Suit
An attorney for special purpose acquisition company investors in a $1.35 billion take-public deal that preceded an affiliate bankruptcy, heavy losses and fraud claims urged Delaware's Supreme Court on Wednesday to reject arguments that the statute of limitations on the claims started ticking at the time of the alleged misrepresentation.
-
January 21, 2026
Former Ga. State Rep. Cops To COVID Loan Fraud
A former Georgia Democratic lawmaker pled guilty Wednesday to charges that she fraudulently obtained pandemic-era unemployment benefits, the Department of Justice said.
-
January 21, 2026
Teva's Inconsistent Args In IUD Trial 'Troubling,' Judge Says
Teva Pharmaceuticals quickly ran afoul of a Georgia federal judge Wednesday in its first trial over alleged defects in its Paragard IUD, as the court chastised the drugmaker's attorneys over "very troubling" inconsistencies in their opening statements to jurors.
-
January 21, 2026
Cresco Accused Of Withholding Revenue Share From Partner
An Ohio company that claims it helped cannabis giant Cresco Labs LLC build its medical and retail marijuana operations in the Buckeye State alleges in a new federal lawsuit that the company bilked it out of promised fees when it expanded its business into adult-use cannabis.
-
January 21, 2026
FTC Mulling Deal With Express Scripts In PBM Case
The Federal Trade Commission is considering a potential settlement with Express Scripts in the agency's case accusing the country's three largest pharmacy benefit managers of inflating insulin prices through rebate schemes.
-
January 21, 2026
Whole Foods Can't Escape Workers' Tobacco Fee Suit
A Texas federal judge refused to toss a proposed class action against Whole Foods from employee health plan participants who challenged a surcharge on workers who used tobacco, ruling allegations should proceed to discovery that the fees violated multiple provisions of federal benefits law.
-
January 21, 2026
Healthcare Workers Seek $12.2M From $28.5M No-Poach Deal
Nearly 12,000 healthcare workers in a $28.5 million settlement with two hospitals that were accused of agreeing not to poach each other's doctors and nurses urged a Pennsylvania federal court to grant approximately $12 million in attorney fees, costs and service awards.
-
January 21, 2026
Fla. Dispensary Exposed Patient Data Via Google, Suit Says
A Florida man is suing a dispensary website in federal court, alleging it has violated federal health confidentiality laws by using Google Analytics Pixel on its website, which he said intercepts and collects private information for use in advertising.
-
January 20, 2026
GoodRx Users Denied Nod For $32M Deal In Data Sharing Row
A California federal judge refused to sign off on a $32 million deal to resolve a proposed class action accusing GoodRx of illegally sharing users' sensitive health data with fellow defendant Criteo and other advertisers, faulting the parties for failing to provide a detailed analysis of the strength of each claim.
-
January 20, 2026
Dentsply Can't Shed Investors' Aligner Injury Cover-Up Suit
Dental supply company Dentsply Sirona Inc. must face a proposed investor class action alleging it covered up medical injuries and other issues affecting an aligner business it acquired for $1 billion, and caused shareholder losses when the injuries were revealed and the acquisition collapsed.
-
January 20, 2026
Opt-In Forms In DaVita Wage Suit Need Revision, Judge Says
A former DaVita worker should amend misleading consent forms she submitted for nurses and technicians seeking to join her wage action against the dialysis giant, a Colorado federal judge recommended Sunday, saying the worker also sent deceptive solicitation materials to potential opt-in plaintiffs.
Expert Analysis
-
Texas Suit Marks Renewed Focus On Service Kickback Theory
After a dormant period at the federal level, a theory of kickback enforcement surrounding nurse educator programs and patient support services resurfaced with a recent state court complaint filed by Texas against Eli Lilly, highlighting for drugmakers the ever-changing nature of enforcement priorities and industry landscapes, say attorneys at Sheppard Mullin.
-
Series
Power To The Paralegals: How And Why Training Must Evolve
Empowering paralegals through new models of education that emphasize digital fluency, interdisciplinary collaboration and human-centered lawyering could help solve workforce challenges and the justice gap — if firms, educators and policymakers get on board, say Kristine Custodio Suero and Kelli Radnothy.
-
Series
Playing Softball Makes Me A Better Lawyer
My time on the softball field has taught me lessons that also apply to success in legal work — on effective preparation, flexibility, communication and teamwork, says Sarah Abrams at Baleen Specialty.
-
5 Years In, COVID-19 Fraud Enforcement Landscape Is Shifting
As the government moves pandemic fraud enforcement from small-dollar individual prosecutions to high-value corporate cases, and billions of dollars remain unaccounted for, companies and defense attorneys must take steps now to prepare for the next five years of scrutiny, says attorney David Tarras.
-
Vanda Ruling Opens Door For Contesting FDA Drug Denials
The D.C. Circuit's recent decision in Vanda Pharmaceuticals v. U.S. Food and Drug Administration creates new opportunities and considerations for drug companies navigating the FDA approval process, establishing that litigation is an option when the FDA refuses to hold a hearing, say attorneys at Polsinelli.
-
Series
Law School's Missed Lessons: Mastering Time Management
Law students typically have weeks or months to prepare for any given deadline, but the unpredictability of practicing in the real world means that lawyers must become time-management pros, ready to adapt to scheduling conflicts and unexpected assignments at any given moment, says David Thomas at Honigman.
-
Courts Keep Upping Standing Ante In ERISA Healthcare Suits
As Article III standing becomes increasingly important in litigation brought by employer-sponsored health plan members under the Employee Retirement Income Security Act, several recent cases suggest that courts are taking a more scrutinizing approach to the standing inquiry in both class actions and individual matters, say attorneys at Crowell & Moring.
-
Calif. Bill May Shake Up Healthcare Investment Landscape
If signed by the governor, newly passed California legislation would significantly expand the Office of Health Care Affordability's oversight of private equity and hedge fund investments in healthcare companies and management services organizations, and raise several questions about companies' data confidentiality and filing burdens, say attorneys at Ropes & Gray.
-
How Hyperlinks Are Changing E-Discovery Responsibilities
A recent e-discovery dispute over hyperlinked data in Hubbard v. Crow shows how courts have increasingly broadened the definition of control to account for cloud-based evidence, and why organizations must rethink preservation practices to avoid spoliation risks, says Bree Murphy at Exterro.
-
Pharma Copay Programs Raise Complex Economic Questions
The growing prevalence of copay accumulator and maximizer programs in the pharmaceutical industry is drawing increased scrutiny from patients, advocacy groups, lawmakers and courts, bringing complex questions about how financial responsibility for prescription drug purchases is determined and complicating damages assessments in litigation, say analysts at Analysis Group.
-
State False Claims Acts Can Help Curb Opioid Fund Fraud
State versions of the federal False Claims Act can play an important role in policing the misuse of opioid settlement funds, taking a cue from the U.S. Department of Justice’s handling of federal fraud cases involving pandemic relief funds, says Kenneth Levine at Stone & Magnanini.
-
'Occurrence' Lessons From Policyholder's COVID Ruling Win
The Minnesota Court of Appeals recently handed policyholders an important win in Life Time v. Zurich American Insurance, reversing a trial court ruling that had capped coverage under a communicable disease endorsement at a single occurrence, showing the importance of fact-specific inquiry, say attorneys at Hunton.
-
Series
Writing Musicals Makes Me A Better Lawyer
My experiences with writing musicals and practicing law have shown that the building blocks for both endeavors are one and the same, because drama is necessary for the law to exist, says Addison O’Donnell at LOIS Law.
-
Series
Adapting To Private Practice: From Va. AUSA To Mid-Law
Returning to the firm where I began my career after seven years as an assistant U.S. attorney in Virginia has been complex, nuanced and rewarding, and I’ve learned that the pursuit of justice remains the constant, even as the mindset and client change, says Kristin Johnson at Woods Rogers.
-
Transmission Security Has A Critical Role In Healthcare
In light of the U.S. Department of Health and Human Services' Office of Civil Rights' continuing enforcement initiative focusing on businesses' accurate and thorough security risk assessments under the Health Insurance Portability and Accountability Act, covered entities should not neglect the importance of transmission security, says John Howard at Clark Hill.